These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 427051)

  • 21. Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation reactions in man and the dog.
    Butler TC; Dudley KH; Johnson D; Roberts SB
    J Pharmacol Exp Ther; 1976 Oct; 199(1):82-92. PubMed ID: 978486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Status epilepticus in pregnancy: effect of phenytoin malabsorption on seizure control.
    Ramsay RE; Strauss RG; Wilder BJ; Willmore LJ
    Neurology; 1978 Jan; 28(1):85-9. PubMed ID: 563542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
    Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
    J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct high-performance liquid chromatographic analysis of p-hydroxyphenyl-phenylhydantoin glucuronide, the final metabolite of phenytoin, in human serum and urine.
    Vree TB; Steegers-Theunissen RP; Baars AM; Hekster YA
    J Chromatogr; 1990 Apr; 526(2):581-9. PubMed ID: 2362000
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.
    Morselli PL; Rizzo M; Garattini S
    Ann N Y Acad Sci; 1971 Jul; 179():88-107. PubMed ID: 5285399
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary hydroxyphenytoin/creatinine ratios as an index of compliance in adult epileptic patients on phenytoin therapy.
    Rambeck B; May T
    Ther Drug Monit; 1984; 6(2):164-72. PubMed ID: 6740735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenytoin serum concentration monitoring during pregnancy and puerperium in Mexican epileptic women.
    Rodríguez-Palomares C; Belmont-Gómez A; Amancio-Chassin O; Estrada-Altamirano A; Herrerías-Cunedo T; Hernández-Serrano M
    Arch Med Res; 1995; 26(4):371-7. PubMed ID: 8555731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
    Ball DE; McLaughlin WS; Seymour RA; Kamali F
    J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free phenytoin monitoring in serum and saliva of epileptic patients in China.
    Cai WM; Zhu GZ; Chen G
    Ther Drug Monit; 1993 Feb; 15(1):31-4. PubMed ID: 8451777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of phenytoin and its metabolites in equine plasma and urine using high-performance liquid chromatography.
    Guan F; Uboh CE; Soma LR; Birks EK; Teleis D; Rudy JA; Watson AO; Tsang DS
    J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(2):209-18. PubMed ID: 11076073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dosage increments on blood phenytoin concentrations.
    Bochner F; Hooper WD; Tyrer JH; Eadie MJ
    J Neurol Neurosurg Psychiatry; 1972 Dec; 35(6):873-6. PubMed ID: 4647859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man.
    Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH
    Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?
    Johno I; Kuzuya T; Suzuki K; Hasegawa M; Nakamura T; Kitazawa S; Aso K; Watanabe K
    Ther Drug Monit; 1988; 10(1):39-44. PubMed ID: 3376180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass fragmentographic determination of diphenylhydantoin and its main metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, in human plasma.
    Hoppel C; Garle M; Elander M
    J Chromatogr; 1976 Jan; 116(1):53-61. PubMed ID: 1245573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematologic effects of phenytoin therapy during pregnancy.
    Strauss RG; Ramsay RE; Willmore LJ; Wilder BJ
    Obstet Gynecol; 1978 Jun; 51(6):682-5. PubMed ID: 662246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the interaction between omeprazole and phenytoin in epileptic patients.
    Andersson T; Lagerström PO; Unge P
    Ther Drug Monit; 1990 Jul; 12(4):329-33. PubMed ID: 2396305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute configuration of (+)-5-(o-hydroxyphenyl)-5-phenylhydantoin, the major metabolite of 5,5-diphenylhydantoin in the dog.
    Maguire JH; Butler TC; Dudley KH
    J Med Chem; 1978 Dec; 21(12):1294-7. PubMed ID: 722736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenytoin metabolism in the cat after long-term oral administration.
    Hassell TM; Maguire JH; Cooper CG; Johnson PT
    Epilepsia; 1984 Oct; 25(5):556-63. PubMed ID: 6479107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma anticonvulsant concentrations during pregnancy.
    Lander CM; Edwards VE; Eadie MJ; Tyrer JH
    Neurology; 1977 Feb; 27(2):128-31. PubMed ID: 556828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.